B7Y Share Price Performance
Recent B7Y News & Updates
No updates
Byotrol plc Key Details
Last Reported Earnings
Sep 30, 2023
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.0041
- Gross Margin
- 42.51%
- Net Profit Margin
- -42.33%
- Debt/Equity Ratio
- 19.7%
Byotrol plc Competitors
About B7Y
- Founded
- 2005
- Employees
- 36
- CEO
- WebsiteView website
Byotrol plc develops and commercialize antimicrobial technologies and products in the United Kingdom, North America, and internationally. The company operates through Professional and Consumer segments. Its product portfolio includes Actizone, a antimicrobial technology which improves cleaning performance and long-lasting protection against bacteria; and Byotrol, a long-lasting antimicrobial protection for various applications including bathroom cleaners to multi-surface wipes. The company also offers HLD4, a broad-spectrum disinfectant designed for high soil environments of the animal health sector; and Invirtu for skin care. It serves human and animal health, facilities management, food and beverages, household, and skin and pet care markets. The company was incorporated in 2005 and is headquartered in Chester, the United Kingdom.
U.K. Market Performance
- 7 Days: -2.5%
- 3 Months: 17.0%
- 1 Year: 12.4%
- Year to Date: 12.2%
Over the last 7 days, the market has dropped 2.5%, driven by a loss of 2.3% in the Financials sector. In the last year, the market is actually up 12%. Looking forward, earnings are forecast to grow by 13% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading